Eli Lilly (NYSE: LLY) may seem like an expensive stock to invest in right now. Its $720 billion market capitalization also means it's the most valuable healthcare stock in the world. It's one that investors should keep a close eye on because it could send the stock to record highs in 2025.

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 504.34% and currently trading at $799.00. The company has been around since 1876 and the stock didn’t go public until 1952 but in the last 4 years,

According to a sneak peek of the data from one of Eli Lilly's (NYSE: LLY) late-stage clinical trials, the cardiometabolic medicine juggernaut now looks even stronger in comparison to its similarly powerful arch-rival,

We recently published a list of 10 Best Safe Stocks To Buy According to Analysts. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other best safe stocks to buy according to analysts.

Shares of Eli Lilly & Co. LLY sank 0.50% to $799.58 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 0.30% to 6,034.91 and Dow Jones Industrial Average DJIA falling 0.

Eli Lilly And Co (NYSE:LLY) announced results from the Phase 3 BRUIN CLL-321 trial evaluating pirtobrutinib in adult patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) previously treated with a covalent BTK inhibitor.

Eli Lilly & Co. closed $168.95 below its 52-week high ($972.53), which the company achieved on August 22nd.